Peter Suenaert, M.D., Ph.D., Head of Global Clinical Development
Peter Suenaert, M.D., Ph.D., serves as Head of Global Clinical Development at AgenTus Therapeutics responsible for the translational, early and pivotal clinical development bringing the Cell Therapy Assets to cancer patients.
He is a digestive oncologist by training and is an expert in clinical development in oncology with ten years of experience in the immune-oncology field in the pharmaceutical and biotech industry.
Prior to working at AgenTus Therapeutics, he held a number of progressively responsible global development positions including Medical Director Oncology Late Phase Development at Amgen, Med Dir Early Clin Development at GSK Bio (Cancer Immunotherapeutics), Oncology Lead at Glenmark Pharma, and Chief Medical Officer at Immunicum AB (IO Cell Therapy).
He holds an MD in Gastroenterology and Digestive Oncology and a PhD in Medical Sciences from Leuven University, Belgium.
Peter completed his post-doc at McGill University Health Center, Canada, and was on staff as Clinical Head Digestive Oncology at the University Hospital Antwerp before joining the pharma industry.